Loading...
Entry LevelFull-time
Salary Range
$40,375 - $54,625 /year
This salary is estimated based on similar roles. The actual salary may vary.
Primary Job Function: 
The primary focus of this new position, within the Finance Shared Services (FSS) organization, is to provide support to the Global Process Lead, Procure to Pay in the sub process area of Vendor Management, specifically to coordinate the centralization of all US Vendor Master Activities into a single group in FSS. 
Currently Vendor Master transactions in all US company codes are very de-centralized, with many infrequent users. This leads to data quality problems, potential audit risks, elongated cycle times and excessive queries placed with the FSS Vendor Master Team This role will coordinate a new team to migrate all the US Vendor Master activities into FSS to reduce processing variability, speed up transaction processing and reduce any risks. 
The role will report to the Global Process Lead, Procure to Pay, be ideally located in Lake County and be able to observe the new Hybrid Working of attending the workplace 3 days a week 
Responsibilities will include, but are not limited to: 
• Be highly involved in the operational preparedness of the new team leading to launch in Q2 2026 
• Prepare Service Level Agreement for transactional processing times and prepare reporting metrics 
• Work with Change Management on the overall communication of the initiative 
• Ongoing Management of the team as the team moves from Launch to Hypercare to Business as Usual. 
• Respond to queries from the US business 
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
